EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Lars Englberger
Hartzell V. Schaff
Thierry P. Carrel
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Englberger, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Englberger, L.
Related Collections
Right arrow Valve disease

Eur J Cardiothorac Surg 2005;28:838-843
© 2005 Elsevier Science NL

Importance of implant technique on risk of major paravalvular leak (PVL) after St. Jude mechanical heart valve replacement: a report from the Artificial Valve Endocarditis Reduction Trial (AVERT)

Lars Englberger a , * , Hartzell V. Schaff b , W.R. Eric Jamieson c , Elizabeth D. Kennard d , Kyung A. Im d , Richard Holubkov e , Thierry P. Carrel a for the AVERT Investigators

a Department of Cardiovascular Surgery, Inselspital, University Hospital, Freiburgstrasse, 3010 Berne, Switzerland
b Mayo Clinic, Rochester, MN, USA
c University of British Columbia, Vancouver, BC, Canada
d University of Pittsburgh, Epidemiology Data Coordinating Center, Pittsburgh, PA, USA
e University of Utah, Salt Lake City, UT, USA

Received 19 November 2004; received in revised form 2 September 2005; accepted 5 September 2005.

* Corresponding author. Tel.: +41 31 632 2375; fax: +41 31 632 4443. (Email: lars.englberger{at}insel.ch).

Objective: To examine risk factors for major paravalvular leak (PVL) events after mechanical heart valve replacement. Methods: We analyzed outcome of 807 patients randomized into the Artificial Valve Endocarditis Reduction Trial (AVERT). The mean follow-up time was 30.6 months and 21 major PVL events were reported. Three additional major PVL events associated with endocarditis were excluded from analysis. All baseline medical history variables, as well as operative parameters (including use of pledgets and suture technique) were examined using Cox regression. Results: Major PVL was reported after 11 aortic, 9 mitral, and 1 double valve replacement. 6/404 (1.5%) patients with conventional valves experienced a major PVL event versus 15/403 (3.7%) in the Silzone group. 10/172 (5.8%) patients with valve suture technique without pledgets experienced a major PVL event versus 11/635 (1.7%) patients with pledgets. Final multivariable model showed that only suture technique without pledgets (p = 0.005) was an independent significant risk factor for major PVL events. Silzone cuff showed a strong trend (p = 0.055). Conclusions: Suture technique without pledgets is an independent significant risk factor for major PVL events. In this study, use of pledgets during valve replacement had a protective effect against subsequent paravalvular leak, supporting the use of buttress reinforcement for valve suture. The use of Silzone cuff, although not statistically significant, showed a strong trend as a risk factor.

Key Words: Valve surgery • Paravalvular leak • Prosthetic valve endocarditis • Risk factors




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
W.R. E. Jamieson, G. J. Fradet, J. G. Abel, M. T. Janusz, S. V. Lichtenstein, J. S. MacNab, E. A. Stanford, and F. Chan
Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1109 - 15.e2.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
F. Farhat, M. Durand, F. Delahaye, and O. Jegaden
Prosthetic valve sewing-ring sealing with antibiotic and fibrin glue in infective endocarditis. A prospective clinical study
Interactive CardioVascular and Thoracic Surgery, February 1, 2007; 6(1): 16 - 20.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. J. Antunes
Editorial comment: How much can we do to reach the ideal valve prosthesis?
Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 843 - 844.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.